Melissa Little | |
---|---|
Born | Brisbane, Queensland, Australia | 5 December 1963
Alma mater |
|
Known for | Developing the world's first kidney in a dish |
Scientific career | |
Fields | Nephrology Stem Cell Organoids |
Institutions | University of Copenhagen, Murdoch Children's Research Institute |
Doctoral advisor | Peter Smith |
Melissa Helen Little is an Australian scientist and academic who has served as director of Cell Biology at the Murdoch Children's Research Institute since 2019. [1] She is also a Professor in the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and Program Leader of Stem Cells Australia. [2] In January 2022, she became CEO of the Novo Nordisk Foundation Center for Stem Cell Medicine reNEW, an international stem cell research center based at University of Copenhagen, and a collaboration between the University of Copenhagen, Denmark, Murdoch Children’s Research Institute, Australia, and Leiden University Medical Center, The Netherlands. [3]
She is internationally recognized both for her work on the systems biology of kidney development and also for her pioneering studies into potential regenerative therapies in the kidney. [4] [5] In 2015, Professor Melissa Little and her team at Murdoch Children’s Research Institute produced the world’s first kidney in a dish. [6] Known today as kidney organoids, this research has become a foundation of ongoing work to find a regenerative solution for kidney disease.
Melissa Little was born in Brisbane, Australia on 5 December 1963, the middle daughter of three girls. Her father, Ian Little, was a soils chemist with the CSIRO Cunningham laboratories. She graduated from Kenmore State High School in 1980. She completed her BSc at the University of Queensland with 1st Class Honours in Physiology in 1984. Her PhD studies were performed in the laboratory of Professor Peter Smith at the Queensland Institute of Medical Research enrolled through Biochemistry at the University of Queensland (conferred 1990). An alumna of the University of Queensland, Brisbane, Australia, Melissa worked for more than 20 years at the Institute for Molecular Bioscience, where her research focused on the molecular basis of kidney development, renal disease and repair. In 2004 she graduated from the Australian Institute of Company Directors.[ citation needed ]
Little started her research career studying Wilm's Tumour, a childhood kidney cancer. She was awarded a Royal Society Endeavour Fellowship to move to the Medical Research Council Human Genetics Unit in Edinburgh to undertake postdoctoral training with Nicholas Hastie. Here she worked on the gene WT1, the gene that is mutated in a subset of Wilm's tumour patients.
She returned to Australia to continue to work on WT1, but concentrating on its essential role in the normal development of the urogenital system. [7] Her work focuses on the molecular aspects of kidney development, with applications to stem cell biology and regenerative medicine.
Little and her team have developed an approach to recapitulate nephrogenesis, the formation of nephrons, in a dish. By knowing where the different kidney cells come from and how they develop she has developed a system to regenerate them from pluripotent stem cells. Using embryonic stem cells, or induced pluripotent stem cells from a patient, her group has described a cocktail of growth factors that can drive development into kidney cells.
The group were able to develop self organising organoids 7mm long over 18 days. [8] [9] These small balls of cells have differentiated most of the cells that form the kidneys, including collecting ducts, podocytes, vasculature cells, nephrons and loops of Henle, and are closely related transcriptionallly to first and second trimester developing kidneys. Further research into the organoids by Prof Little's Laboratory has demonstrated robust transcriptional reproducibility of the model [10] and utilised induced pluripotent stem cells generated from patients to study their kidney disease. [11] [12]
In the late 1990s, Little was a member of the Strategic Review of Health and Medical Research, chaired by Peter Wills. [13] This review [14] proposed a Virtuous Cycle between research, government and the commercial sector . As a result of these recommendations, the budget of the National Health and Medical Research Council was doubled over the next 10 years. She went on to serve on the Implementation Committee of that review and served under Robin Batterham, Chief Scientist, to identify strategic priorities across Australian science. A member of the NHMRC Research Committee for 6 years, she was also a member of the most recent review of health and medical research, chaired by Simon McKeon, which led to the establishment of the Medical Research Future Fund [15] and the Biomedical Translation Fund. [16]
Little is the 2021-2022 President of the International Society for Stem Cell Research [17] and Program Leader of Stem Cells Australia, [18] an organisation that aims to "Bring together Australia's premier life scientists to tackle the big questions in stem cell science". She is also a guest editor with the scientific journal Development. [19] She is the serving theme director of Cell Biology [20] at the Murdoch Childrens Research Institute and directs the MCRI Stem Cell Medicine Strategic Priority area. She is also the President of the Australasian Society for Stem Cell Research and a Board Member of the International Society for Stem Cell Research.
An organoid is a miniaturised and simplified version of an organ produced in vitro in three dimensions that mimics the key functional, structural, and biological complexity of that organ. It is derived from one or a few cells from a tissue, embryonic stem cells, or induced pluripotent stem cells, which can self-organize in three-dimensional culture owing to their self-renewal and differentiation capacities. The technique for growing organoids has rapidly improved since the early 2010s, and The Scientist named it one of the biggest scientific advancements of 2013. Scientists and engineers use organoids to study development and disease in the laboratory, for drug discovery and development in industry, personalized diagnostics and medicine, gene and cell therapies, tissue engineering, and regenerative medicine.
Ruth Frances Bishop was an Australian virologist, who was a leading member of the team that discovered the human rotavirus.
IFT140, Intraflagellar transport 140 homolog, is a protein that in humans is encoded by the IFT140 gene. The gene product forms a core component of IFT-A complex which is indipensible for retrograde intraflagellar transport within the primary cilium.
Katharina Gaus was a German-Australian immunologist and molecular microscopist. She was an NHMRC Senior Research Fellow and founding head of the Cellular Membrane Biology Lab, part of the Centre for Vascular Research at the University of New South Wales. Gaus used new super-resolution fluorescence microscopes to examine the plasma membrane within intact living cells, and study cell signalling at the level of single molecules to better understand how cells "make decisions". A key discovery of Gaus and her team was how T-cells decide to switch on the body's immune system to attack diseases. Her work is of importance to the development of drugs that can work with T-cells in support of the immune system.
Amanda Jane Fosang is a biomedical researcher who has pioneered arthritis research in Australia.
Josephine Forbes is an Australian scientist specialising in the study of glycation and diabetes. She has been studying diabetes since 1999 and has worked at Royal Children's Hospital, University of Melbourne and Baker Heart and Diabetes Institute in Melbourne Australia. Since 2012 she has led the Glycation and Diabetes team at Mater Research which is a world-class medical research institute based at South Brisbane, and part of the Mater Group. Josephine is program leader for Mater's Chronic Disease Biology and Care theme, building greater understanding of the biological basis of a broad range of chronic diseases, and developing preventative strategies and innovative treatments to improve patient outcomes. Josephine and her team focus on how advanced glycation contributes to the pathogenesis of diabetes and its complications such as kidney disease.
Jane Visvader is a scientist specialising in breast cancer research who works for the Walter and Eliza Hall Institute in Melbourne, Australia. She is the joint head of the Breast Cancer Laboratory with Geoff Lindeman.
Aleksandra Filipovska is an Australian biochemist and molecular biologist. She is a professor, Deputy Director of the ARC Centre of Excellence in Synthetic Biology and NHMRC Investigator at the University of Western Australia, heading a research group at the Telethon Kids Institute. Specializing in biochemistry and molecular biology, she has made contributions to the understanding of human mitochondrial genetics in health and disease.
The Murdoch Children's Research Institute (MCRI) is an Australian paediatric medical research institute located in Melbourne, Victoria, affiliated with the Royal Children's Hospital and the University of Melbourne. The institute has six research themes: stem cell medicine, clinical sciences, genetics, infection and immunity, population health, and data science.
Jeanne Frances Loring is an American stem cell biologist, developmental neurobiologist, and geneticist. She is the founding Director of the Center for Regenerative Medicine and emeritus professor at the Scripps Research Institute in La Jolla, California. She has founded two biotechnology companies, Arcos BioScience (1999) and Aspen Neuroscience (2018)
Marguerite Virginia Evans-Galea is the co-founder of Women in STEMM Australia. STEMM. Her research is focused on gene therapy and neurodegenerative diseases.
Melissa Anne Wake is a New Zealand paediatrician and scientific director of the Generation Victoria initiative, which states the aim of creating very large, parallel whole-of-state birth and parent cohorts in Victoria, Australia, for Open Science discovery and interventional research. She is group leader of the Murdoch Children's Research Institute's Prevention Innovation Research Group and holds professorial positions with the University of Melbourne and the University of Auckland.
Misty Rayna Jenkins is an Australian scientist known for her research into lymphocytes and cancer treatment.
Cynthia B. Whitchurch is an Australian microbiologist. Whitchurch is the research director of the Biofilm Biology cluster at the Singapore Centre For Environmental Life Sciences Engineering (SCELSE) and a Professor at the School Of Biological Sciences at Nanyang Technological University (NTU), Singapore. She was previously a research group leader at the Quadram Institute on the Norwich Research Park in the United Kingdom and the founding director of the Microbial Imaging Facility and a Research Group Leader in the Institute of Infection, Immunity and Innovation at the University of Technology Sydney (UTS) in New South Wales.
Christine L. Mummery (1953) is an appointed professor of Developmental Biology at Leiden University and the head of the Department of Anatomy and Embryology at Leiden University Medical Center in the Netherlands.
Paola Arlotta is the Golub Family Professor of Stem Cell and Regenerative Biology at Harvard University and chair of the Harvard Stem Cell and Regenerative Biology (HSCRB). Her research focuses on the development of neuron types in the cerebral cortex. She is best known for her work using 3D cerebral organoids derived from human induced pluripotent stem cells (iPSCs) to study cortical development in neurodegenerative and neuropsychiatric disorders.
Jenny Hsieh is an American cell biologist and Semmes Foundation professor at the University of Texas at San Antonio (UTSA). Her work focuses on epilepsy and stem cell biology.
Samira Musah is an American biomedical engineer and professor at the Duke University Pratt School of Engineering. She is known for her work in biomimetic systems, in particular for her work in developing an organ-on-a-chip model of the kidney glomerulus during her postdoctoral fellowship.
Julie Bines, is a clinician and researcher working in Melbourne, Australia. Alongside being a professor and deputy head of the Department of Paediatrics at the University of Melbourne, she is also a paediatric gastroenterologist at the Royal Children's Hospital Melbourne and is the leader of the Enteric Diseases group at the Murdoch Children's Research Institute. Bines is the joint head of the WHO Collaborative Centre for Child Health and founding member of Women in Global Health Australia.
Sharon Goldfeld is a paediatrician and public health physician, who is Director of the Centre for Community and Child Health at the Royal Children's Hospital, Co-Group Leader of the Policy and Equity Research Group, and Theme Director, Population Health, at the Murdoch Children's Research Institute.